Implant survivorship analysis after minimally invasive sacroiliac joint fusion using the iFuse Implant System®
Authors Cher D, Reckling WC, Capobianco R
Received 21 August 2015
Accepted for publication 23 October 2015
Published 23 November 2015 Volume 2015:8 Pages 485—492
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Di Lang
Peer reviewer comments 3
Editor who approved publication: Dr Scott Fraser
Daniel J Cher,1 W Carlton Reckling,2 Robyn A Capobianco1
1Department of Clinical Affairs, SI-BONE, Inc., 2Department of Medical Affairs, SI-BONE, Inc., San Jose, CA, USA
Introduction: Surgical revision rate is a key outcome with all permanent implants. The iFuse Implant System® is a permanent implant used to perform minimally invasive sacroiliac joint fusion. The purpose of this study is to determine the surgical revision rate after sacroiliac joint fusion surgery with this system.
Methods: Using two internal sources of information, revision surgeries were identified and linked to index surgeries. The likelihood of revision surgery was calculated using the Kaplan–Meier life table approach. Predictors of revision were explored.
Results: Four-year survivorship free from implant revision was 96.46%. Revision rate did not differ by sex and was lower for age >65. In all, 24% of revisions occurred within the first 30 days after surgery; 63.5% occurred within year 1. Implant survivorship has improved annually since the device was introduced in 2009.
Conclusion: The survivorship rate with this implant is high and improving; the rate is somewhat higher than total hip replacement but lower than that of lumbar spine procedures.
Keywords: safety, sacroiliac joint fusion, iFuse Implant System, revision
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]